Abbott/$ABT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Ticker
$ABT
Sector
Primary listing
NYSE
Employees
114,000
Headquarters
Website
Abbott Metrics
BasicAdvanced
$217B
15.70
$7.96
0.72
$2.32
1.89%
Price and volume
Market cap
$217B
Beta
0.72
52-week high
$141.23
52-week low
$110.86
Average daily volume
6.2M
Dividend rate
$2.32
Financial strength
Current ratio
1.703
Quick ratio
1.088
Long term debt to equity
22.686
Total debt to equity
25.31
Dividend payout ratio (TTM)
28.93%
Interest coverage (TTM)
16.93%
Profitability
EBITDA (TTM)
11,747
Gross margin (TTM)
56.14%
Net profit margin (TTM)
31.88%
Operating margin (TTM)
19.65%
Effective tax rate (TTM)
-71.75%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
6.79%
Return on equity (TTM)
30.62%
Valuation
Price to earnings (TTM)
15.697
Price to revenue (TTM)
4.96
Price to book
4.26
Price to tangible book (TTM)
10.16
Price to free cash flow (TTM)
31.442
Free cash flow yield (TTM)
3.18%
Free cash flow per share (TTM)
3.974
Dividend yield (TTM)
1.86%
Forward dividend yield
1.89%
Growth
Revenue change (TTM)
6.37%
Earnings per share change (TTM)
141.96%
3-year revenue growth (CAGR)
-0.89%
10-year revenue growth (CAGR)
7.86%
3-year earnings per share growth (CAGR)
21.57%
10-year earnings per share growth (CAGR)
10.24%
3-year dividend per share growth (CAGR)
7.87%
10-year dividend per share growth (CAGR)
9.41%
What the Analysts think about Abbott
Analyst ratings (Buy, Hold, Sell) for Abbott stock.
Bulls say / Bears say
Abbott's medical devices division reported $5.37 billion in sales in Q2, outpacing analyst expectations and fueling overall revenue growth. (Reuters)
Continuous glucose monitor sales jumped 21.4% year-over-year to $1.9 billion in Q2, showing continued strength in Diabetes Care. (Reuters)
Medical devices sales climbed 14.8% to $5.45 billion in Q3, underscoring strong demand for Abbott’s heart devices despite broader macroeconomic challenges. (Reuters)
Diagnostics revenue dropped 6.6% year-over-year to $2.25 billion in Q3, pressured by declining COVID-19 testing demand and pricing challenges in China. (Reuters)
Abbott's pediatric nutrition division is facing legal action over alleged links between its specialty formulas and necrotizing enterocolitis, presenting possible litigation risks. (Reuters)
The company tightened its full-year adjusted EPS forecast to $5.12–$5.18 from $5.10–$5.20, underscoring persistent uncertainty in its diagnostics and nutrition businesses. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Nov 2025.
Abbott Financial Performance
Revenues and expenses
Abbott Earnings Performance
Company profitability
Abbott News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Abbott stock?
Abbott (ABT) has a market cap of $217B as of November 08, 2025.
What is the P/E ratio for Abbott stock?
The price to earnings (P/E) ratio for Abbott (ABT) stock is 15.7 as of November 08, 2025.
Does Abbott stock pay dividends?
Yes, the Abbott (ABT) stock pays dividends to shareholders. As of November 08, 2025, the dividend rate is $2.32 and the yield is 1.89%. Abbott has a payout ratio of 28.93% on a trailing twelve-month basis.
When is the next Abbott dividend payment date?
The next Abbott (ABT) dividend payment is scheduled for November 17, 2025.
What is the beta indicator for Abbott?
Abbott (ABT) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.